3
describing the anatomy and physiology of the human organism with its tissues, organs 4 and sub-compartments (Fig. SI 1) , 2) physiochemical properties (e.g. lipophilicity 5 coefficient or the fraction of unbound drug) of the modeled compounds used to describe 6 passive absorption and diffusion processes, and 3) kinetic parameters characterizing Michaelis-Menten kinetics were used to describe the reaction rates. Tissue specific 15 relative enzyme and transporter abundances were quantified by gene expression data 16 provided by the PBPK modeling software (1).
17
Since each of the considered metabolites is found in the urine (2, 3), renal excretion 18 processes for these all metabolites were integrated into the PBPK model. For 51 
